Remove 2016 Remove Licensing Remove Marketing Remove Public Use
article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

Yet 2020 saw a slowdown in biosimilar activity with the lowest number of annual biosimilar approvals since 2016 and fewer product launches than 2019—as well as a decrease in district court litigation and post-grant proceedings. 2016; resubmitted May 2018). Legislation Relating to Biologics and Biosimilars. BPCIA Litigation. Neulasta ®.

article thumbnail

Intellectual Property Tools for Protecting Fashion Goods

LexBlog IP

Fashion companies should be aware that they may need to obtain a license to, or ownership of, the copyright from the photographer. The next time you would like to protect a great innovative design you expect will be a big hit on the market, you should consider obtaining a design patent. Scenario 2: Protecting Novel Designs by Patent.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Intellectual Property Tools for Protecting Fashion Goods

Above the Fold

Fashion companies should be aware that they may need to obtain a license to, or ownership of, the copyright from the photographer. The next time you would like to protect a great innovative design you expect will be a big hit on the market, you should consider obtaining a design patent. Scenario 2: Protecting Novel Designs by Patent.

article thumbnail

The US’ Review of March-in Rights, and Some Questions on an Indian Counterpart

SpicyIP

According to the NIST, the US govt invests approximately $115 billion in R&D through various universities, non-profits, and businesses. March-in rights are provisions that allow the government to require a license for inventions stemming from this investment, upon the fulfilment of certain conditions.